Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access

• US 7,319,905 B1
• Filed: 05/03/2005
• Issued: 01/15/2008
• Est. Priority Date: 11/30/2004
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: McGarvey, Andrew W., Morgan, Kevin L., Yang, Michael, Williams, Sheldon
• Primary Examiner(s): Layno; Carl
• Assistant Examiner(s): MORALES, JON ERIC C
• Application Number:
  US11/121,881
• Time in Patent Office: 987 Days
• Field of Search: 607/115, 607/116, 607/119, 607/122, 607/123, 607/125, 607/126, 600/372, 600/373, 600/374, 600/377, 600/381
• US Class Current: 607/129
• CPC Class Codes: A61N 1/0587 Epicardial electrode systems; Endocardial electrodes piercing the pericardium

Abstract

An implantable lead having an elongated lead body that includes an electrical conductor extending between a distal end of the lead body and a proximal end of the lead body is disclosed. The lead further includes an electrode formed at the distal end of the lead body, the electrode being coupled to the electrical conductor and one or more passive fixation mesh sections coupled to the distal end of the lead body that promotes tissue over growth.

Claims

1. An implantable lead system, comprising:

an elongated lead body defining a longitudinal axis and comprising an electrical conductor extending between a distal end of the lead body and a proximal end of the lead body;

an electrode mounted on the distal end of the lead body, the electrode being coupled to the electrical conductor;

one or more passive fixation mesh sections coupled to the lead body that encourage tissue over growth and is adapted to transition between a collapsed state wherein it is at least partially wrapped around the lead body and an extended state wherein it projects outward from the lead body; and

one or more contact points integrated on the lead body, the contact points being adapted to promote overgrowth of cardiac tissue thereon;

wherein a shape of at least one of the one or more passive fixation mesh sections is asymmetric about the longitudinal axis of the lead body when in an extended state.

2. The implantable lead system of claim 1 further comprising a fluoroscopic marker disposed on one of the one or more passive fixation mesh sections.

3. The implantable lead system of claim 1 wherein the one or more passive fixation mesh sections include a silicone edging around a perimeter of the mesh sections.

4. The implantable lead system of claim 3 wherein the silicone edging around a perimeter of the mesh sections is impregnated with a fluoroscopically visible material to visualize the perimeters of the one or more mesh sections under fluoroscopy.

5. The implantable lead system of claim 3 wherein the one or more mesh sections comprise an absorbable mesh weave with a permanent biocompatible perimeter edging.

6. The implantable lead system of claim 1 further comprising a first fluoroscopic marker having a first shape disposed on a first section of the at least one passive fixation section located on a first side of the longitudinal axis and a second fluoroscopic marker having a second shape different from the first shape and disposed on a second section of the at least one passive fixation section located on a second side of the longitudinal axis opposite the first side.

7. The implantable lead system of claim 1 wherein the one or more contact points comprises a polymer sleeve coupled to the lead body.

8. The implantable lead system of claim 1 further comprising an inflatable member proximal of said electrode, wherein the inflatable member is adapted to passively fixate the lead in place prior to tissue overgrowth on the one or more passive fixation mesh sections.

9. The implantable lead system of claim 8 further comprising an inflation lumen coupled between the inflatable member and a side arm so that an inflation material can be injected through said inflation lumen to inflated said inflatable member.

10. The implantable lead system of claim 1 wherein one of the one or more passive fixation mesh sections is coupled to the distal end of the lead body.

11. The implantable lead system of claim 10 wherein the one passive fixation mesh section coupled to the distal end of the lead body covers a portion of the electrode.

12. The implantable lead system of claim 1 wherein one of the one or more contact points is integrated on the distal end of the lead body.

13. An implantable lead system, comprising:

an elongated lead body defining a longitudinal axis and comprising an electrical conductor extending between a distal end of the lead body and a proximal end of the lead body;

an electrode mounted on the distal end of the lead body, the electrode being coupled to the electrical conductor; and

one or more passive fixation mesh sections coupled to the lead body that encourages tissue over growth and is adapted to transition between a collapsed state wherein it is at least partially wrapped around the lead body and an extended state wherein it projects outward from the lead body, wherein a shape of at least one of the one or more passive fixation mesh sections is asymmetric about the longitudinal axis of the lead body when in an extended state.

14. The implantable lead system of claim 13 further comprising a fluoroscopic marker disposed on one of the one or more passive fixation mesh sections.

15. The implantable lead system of claim 13 wherein the one or more passive fixation mesh sections include a silicone edging around a perimeter of the mesh sections.

16. The implantable lead system of claim 15 wherein the silicone edging around a perimeter of the mesh sections is impregnated with a fluoroscopically visible material to visualize the perimeters of the one or more mesh sections under fluoroscopy.

17. The implantable lead system of claim 13 wherein the one or more mesh sections comprise an absorbable mesh weave with a permanent biocompatible perimeter edging.

18. The implantable lead system of claim 13 further comprising an inflatable member proximal of said electrode, wherein the inflatable member is adapted to passively fixate the lead in place prior to tissue overgrowth on the one or more passive fixation mesh sections.

19. The implantable lead system of claim 13 further comprising one or more contact points integrated on the lead body, the contact points being adapted to promote overgrowth of cardiac tissue thereon.

20. The implantable lead system of claim 19 wherein the one or more contact points comprises a polymer sleeve coupled to the lead body.

21. The implantable lead system of claim 13 wherein one of the one or more passive fixation mesh sections is coupled to the distal end of the lead body.

22. The implantable lead system of claim 21 wherein the one passive fixation mesh section coupled to the distal end of the lead body covers a portion of the electrode.